prednisone has been researched along with epz-6438 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copeland, RA; Iwanowicz, D; Johnston, LD; Keilhack, H; Klaus, CR; Knutson, SK; Kuntz, KW; Littlefield, BA; Moyer, MP; Pollock, RM; Porter-Scott, M; Raimondi, A; Smith, JJ; Warholic, NM; Wigle, TJ | 1 |
| Abramson, JS | 1 |
| Cullières-Dartigues, P; Dubois, R; Dubois, S; Herbaux, C; Jardin, F; Karlin, L; Le Gouill, S; Michot, JM; Molina, T; Morschhauser, F; Picquenot, JM; Ribrag, V; Salles, G; Sarkozy, C; Suttle, B; Tilly, H | 1 |
| Cahill, KE; Smith, SM | 1 |
2 review(s) available for prednisone and epz-6438
| Article | Year |
|---|---|
Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biphenyl Compounds; Cyclophosphamide; Doxorubicin; Enhancer of Zeste Homolog 2 Protein; Etoposide; Gene Expression Profiling; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Molecular Diagnostic Techniques; Morpholines; Mutation; Prednisone; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Pyridones; Receptors, Chimeric Antigen; Risk; Rituximab; Translocation, Genetic; Vincristine | 2019 |
Follicular Lymphoma: a Focus on Current and Emerging Therapies
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Benzamides; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Genetic Testing; Humans; Immune Checkpoint Inhibitors; Immunoconjugates; Immunotherapy, Adoptive; Lenalidomide; Lymphoma, Follicular; Maintenance Chemotherapy; Morpholines; Neoplasm Recurrence, Local; Phosphoinositide-3 Kinase Inhibitors; Prednisone; Pyridones; Rituximab; Sulfonamides; Vincristine | 2022 |
1 trial(s) available for prednisone and epz-6438
| Article | Year |
|---|---|
A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) plus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) with Poor Prognosis Features.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Biphenyl Compounds; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Morpholines; Neoplasm Grading; Neoplasm Staging; Prednisone; Prognosis; Pyridones; Retreatment; Rituximab; Treatment Outcome; Vincristine | 2020 |
1 other study(ies) available for prednisone and epz-6438
| Article | Year |
|---|---|
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Evaluation, Preclinical; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Lymphoma, Non-Hodgkin; Mice, SCID; Morpholines; Neoplasm Transplantation; Prednisolone; Prednisone; Pyridones; Random Allocation; Receptors, Glucocorticoid; Vincristine | 2014 |